NASDAQ
DH

Definitive Healthcare Corp

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

Definitive Healthcare Corp Stock Price

Vitals

Today's Low:
$8.86
Today's High:
$9.125
Open Price:
$9.03
52W Low:
$8.71
52W High:
$30.11
Prev. Close:
$9.04
Volume:
526821

Company Statistics

Market Cap.:
$1.19 billion
Book Value:
8.969
Revenue TTM:
$231.73 million
Operating Margin TTM:
-14.22%
Gross Profit TTM:
$196.79 million
Profit Margin:
-3.98%
Return on Assets TTM:
-0.97%
Return on Equity TTM:
-1.67%

Company Profile

Definitive Healthcare Corp had its IPO on 2021-09-15 under the ticker symbol DH.

The company operates in the Healthcare sector and Health Information Services industry. Definitive Healthcare Corp has a staff strength of 946 employees.

Stock update

Shares of Definitive Healthcare Corp opened at $9.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $8.86 - $9.13, and closed at $9.07.

This is a +0.33% increase from the previous day's closing price.

A total volume of 526,821 shares were traded at the close of the day’s session.

In the last one week, shares of Definitive Healthcare Corp have slipped by -1.63%.

Definitive Healthcare Corp's Key Ratios

Definitive Healthcare Corp has a market cap of $1.19 billion, indicating a price to book ratio of 1.4105 and a price to sales ratio of 6.1928.

In the last 12-months Definitive Healthcare Corp’s revenue was $231.73 million with a gross profit of $196.79 million and an EBITDA of $21.66 million. The EBITDA ratio measures Definitive Healthcare Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Definitive Healthcare Corp’s operating margin was -14.22% while its return on assets stood at -0.97% with a return of equity of -1.67%.

In Q1, Definitive Healthcare Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 18.1%.

Definitive Healthcare Corp’s PE and PEG Ratio

Forward PE
58.4795
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.09 per share while it has a forward price to earnings multiple of 58.4795 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Definitive Healthcare Corp’s profitability.

Definitive Healthcare Corp stock is trading at a EV to sales ratio of 5.9706 and a EV to EBITDA ratio of 49.6041. Its price to sales ratio in the trailing 12-months stood at 6.1928.

Definitive Healthcare Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$2.12 billion
Total Liabilities
$142.62 million
Operating Cash Flow
$-33470000.00
Capital Expenditure
$1.34 million
Dividend Payout Ratio
0%

Definitive Healthcare Corp ended 2024 with $2.12 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.12 billion while shareholder equity stood at $988.08 million.

Definitive Healthcare Corp ended 2024 with $78.32 million in deferred long-term liabilities, $142.62 million in other current liabilities, 110000.00 in common stock, $-35531000.00 in retained earnings and $1.32 billion in goodwill. Its cash balance stood at $124.96 million and cash and short-term investments were $343.92 million. The company’s total short-term debt was $11,953,000 while long-term debt stood at $252.47 million.

Definitive Healthcare Corp’s total current assets stands at $421.49 million while long-term investments were $0 and short-term investments were $218.96 million. Its net receivables were $51.80 million compared to accounts payable of $4.54 million and inventory worth $0.

In 2024, Definitive Healthcare Corp's operating cash flow was $-33470000.00 while its capital expenditure stood at $1.34 million.

Comparatively, Definitive Healthcare Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$9.07
52-Week High
$30.11
52-Week Low
$8.71
Analyst Target Price
$13.73

Definitive Healthcare Corp stock is currently trading at $9.07 per share. It touched a 52-week high of $30.11 and a 52-week low of $30.11. Analysts tracking the stock have a 12-month average target price of $13.73.

Its 50-day moving average was $10.59 and 200-day moving average was $11 The short ratio stood at 6.32 indicating a short percent outstanding of 0%.

Around 157.4% of the company’s stock are held by insiders while 10494.4% are held by institutions.

Frequently Asked Questions About Definitive Healthcare Corp

The stock symbol (also called stock or share ticker) of Definitive Healthcare Corp is DH

The IPO of Definitive Healthcare Corp took place on 2021-09-15

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$1838.6
-45.35
-2.41%
$85.19
1.36
+1.62%
$0.84
-0.01
-1.18%
$788.55
-13.6
-1.7%
$3803.75
176.25
+4.86%
$404.7
-29.75
-6.85%
$3.16
-0.02
-0.63%
$78.71
-11.17
-12.43%
$21.23
-0.13
-0.61%
$111.7
-5.3
-4.53%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

Address

550 Cochituate Road, Framingham, MA, United States, 01701